Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros











Intervalo de año de publicación
1.
Future Med Chem ; 10(8): 863-878, 2018 04 01.
Artículo en Inglés | MEDLINE | ID: mdl-29589477

RESUMEN

AIM: Metronidazole is the most widely used drug in trichomoniasis therapy. However, the emergence of metronidazole-resistant Trichomonas vaginalis isolates calls for the search for new drugs to counter the pathogenicity of these parasites. RESULTS: Classification models for predicting the antitrichomonas activity of molecules were built. These models were employed to screen antiprotozoal drugs, from which 20 were classified as active. The in vitro experiments showed moderate to high activity for 19 of the molecules at 10 µg/ml, while 3 compounds yielded higher activity than the reference at 1 µg/ml. The 11 most active chemicals were evaluated in vivo using Naval Medical Research Institute (NMRI) mice. CONCLUSION: Benznidazole showed similar results as metronidazole, and can thus be considered as a potential candidate in antitrichomonas therapy.


Asunto(s)
Antiprotozoarios/química , Antiprotozoarios/farmacología , Reposicionamiento de Medicamentos/métodos , Tricomoniasis/tratamiento farmacológico , Trichomonas vaginalis/efectos de los fármacos , Animales , Antiprotozoarios/uso terapéutico , Análisis Discriminante , Resistencia a Medicamentos , Femenino , Humanos , Metronidazol/química , Metronidazol/farmacología , Metronidazol/uso terapéutico , Ratones , Nitroimidazoles/química , Nitroimidazoles/farmacología , Nitroimidazoles/uso terapéutico , Vaginitis por Trichomonas/tratamiento farmacológico
2.
Bioorg Med Chem ; 22(5): 1568-85, 2014 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-24513185

RESUMEN

Protozoan parasites have been one of the most significant public health problems for centuries and several human infections caused by them have massive global impact. Most of the current drugs used to treat these illnesses have been used for decades and have many limitations such as the emergence of drug resistance, severe side-effects, low-to-medium drug efficacy, administration routes, cost, etc. These drugs have been largely neglected as models for drug development because they are majorly used in countries with limited resources and as a consequence with scarce marketing possibilities. Nowadays, there is a pressing need to identify and develop new drug-based antiprotozoan therapies. In an effort to overcome this problem, the main purpose of this study is to develop a QSARs-based ensemble classifier for antiprotozoan drug-like entities from a heterogeneous compounds collection. Here, we use some of the TOMOCOMD-CARDD molecular descriptors and linear discriminant analysis (LDA) to derive individual linear classification functions in order to discriminate between antiprotozoan and non-antiprotozoan compounds as a way to enable the computational screening of virtual combinatorial datasets and/or drugs already approved. Firstly, we construct a wide-spectrum benchmark database comprising of 680 organic chemicals with great structural variability (254 of them antiprotozoan agents and 426 to drugs having other clinical uses). This series of compounds was processed by a k-means cluster analysis in order to design training and predicting sets. In total, seven discriminant functions were obtained, by using the whole set of atom-based linear indices. All the LDA-based QSAR models show accuracies above 85% in the training set and values of Matthews correlation coefficients (C) vary from 0.70 to 0.86. The external validation set shows rather-good global classifications of around 80% (92.05% for best equation). Later, we developed a multi-agent QSAR classification system, in which the individual QSAR outputs are the inputs of the aforementioned fusion approach. Finally, the fusion model was used for the identification of a novel generation of lead-like antiprotozoan compounds by using ligand-based virtual screening of 'available' small molecules (with synthetic feasibility) in our 'in-house' library. A new molecular subsystem (quinoxalinones) was then theoretically selected as a promising lead series, and its derivatives subsequently synthesized, structurally characterized, and experimentally assayed by using in vitro screening that took into consideration a battery of five parasite-based assays. The chemicals 11(12) and 16 are the most active (hits) against apicomplexa (sporozoa) and mastigophora (flagellata) subphylum parasites, respectively. Both compounds depicted good activity in every protozoan in vitro panel and they did not show unspecific cytotoxicity on the host cells. The described technical framework seems to be a promising QSAR-classifier tool for the molecular discovery and development of novel classes of broad-antiprotozoan-spectrum drugs, which may meet the dual challenges posed by drug-resistant parasites and the rapid progression of protozoan illnesses.


Asunto(s)
Antiprotozoarios/farmacología , Quinoxalinas/síntesis química , Ciclización , Estructura Molecular , Relación Estructura-Actividad Cuantitativa , Quinoxalinas/química
3.
Chem Biol Drug Des ; 80(1): 38-45, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22405194

RESUMEN

Atom-based bilinear indices and linear discriminant analysis are used to discover novel trypanosomicidal compounds. The obtained linear discriminant analysis-based quantitative structure-activity relationship models, using non-stochastic and stochastic indices, provide accuracies of 89.02% (85.11%) and 89.60% (88.30%) of the chemicals in the training (test) sets, respectively. Later, both models were applied to the virtual screening of 18 in-house synthesized compounds to find new pro-lead antitrypanosomal agents. The in vitro antitrypanosomal activity of this set against epimastigote forms of Trypanosoma cruzi is assayed. Predictions agree with experimental results to a great extent (16/18) of the chemicals. Sixteen compounds show more than 70% of epimastigote inhibition at a concentration 100 µg/mL. In addition, three compounds (CRIS 112, CRIS 140 and CRIS 147) present more than 70% of epimastigote inhibition at a concentration of 10 µg/mL (79.95%, 73.97% and 78.13%, respectively) with low values of cytotoxicity (19.7%, 7.44% and 20.63%, correspondingly).Taking into account all these results, we could say that these three compounds could be optimized in forthcoming works. Even though none of them resulted more active than nifurtimox, the current results constitute a step forward in the search for efficient ways to discover new lead antitrypanosomals.


Asunto(s)
Tripanocidas/química , Animales , Línea Celular , Supervivencia Celular/efectos de los fármacos , Análisis Discriminante , Ratones , Relación Estructura-Actividad Cuantitativa , Tripanocidas/toxicidad , Trypanosoma cruzi/efectos de los fármacos
4.
Eur J Med Chem ; 46(8): 3324-30, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21605926

RESUMEN

Two-dimensional bond-based linear indices and linear discriminant analysis are used in this report to perform a quantitative structure-activity relationship study to identify new trypanosomicidal compounds. A database with 143 anti-trypanosomal and 297 compounds having other clinical uses, are utilized to develop the theoretical models. The best discriminant models computed using bond-based linear indices provides accuracies greater than 90 for both training and test sets. Our models identify as anti-trypanosomals five out of nine compounds of a set of already-synthesized substances. The in vitro anti-trypanosomal activity of this set against epimastigote forms of Trypanosoma cruzi is assayed. Both models show a perfect agreement between theoretical predictions and experimental results. The compounds identified as active ones show more than 98% of anti-epimastigote elimination (AE) at a concentration of 100 µg/mL. Besides, three compounds show more than 70% of AE at a concentration of 10 µg/mL. Finally, compounds with the best "activity against epimastigote forms/unspecific cytotoxicity" ratio are evaluated using an amastigote susceptibility assay. It should be noticed that, compound Va7-71 exhibit a 100% of intracellular amastigote elimination and shows similar activity when compared to a standard trypanosomicidal as nifurtimox. Finally, we can emphasize that, the present algorithm constitutes a step forward in the search for efficient ways of discovering new anti-trypanosomal compounds.


Asunto(s)
Supervivencia Celular/efectos de los fármacos , Descubrimiento de Drogas/métodos , Estadios del Ciclo de Vida/efectos de los fármacos , Tripanocidas/química , Trypanosoma cruzi/efectos de los fármacos , Algoritmos , Animales , Enfermedad de Chagas/tratamiento farmacológico , Enfermedad de Chagas/parasitología , Bases de Datos Factuales , Análisis Discriminante , Fibroblastos/parasitología , Ensayos Analíticos de Alto Rendimiento , Humanos , Ligandos , Modelos Teóricos , Relación Estructura-Actividad Cuantitativa , Programas Informáticos , Tripanocidas/farmacología , Trypanosoma cruzi/crecimiento & desarrollo
5.
Rev. biol. trop ; Rev. biol. trop;56(4): 1645-1652, Dec. 2008. ilus, tab
Artículo en Español | LILACS | ID: lil-637769

RESUMEN

Steroidal saponins from the plant Agave brittoniana with activity against the parasite Trichomona vaginalis. The genus Agave (Agavaceae), includes more than 300 species; around 16 of them show an homogeneous distribution throughout Cuba. Agave brittoniana (ssp. brachypus), is an endemic subspecies that grows in the central region of the country and its leaves are traditionally used in the treatment of parasitic diseases. The parasite Trichomonas vaginalis causes the disease known as trichomoniasis, that infects the genital tract. To test in vitro the plant against Trichomona vaginalis, the dried and powdered leaves were extracted three times with ethanol-water (7 : 3) by maceration at room temperature. The solvent was removed under reduced pressure and the extract was suspended in distilled water, defatted with n-hexane, and extracted with water-saturated n-butanol. After solvent removal, a portion of the n-butanol extract was hydrolyzed. After extraction with ethyl acetate the hydrolysis products were compared with authentic sapogenins samples using thin layer chromatography (TLC). Most of the sapogenins (yuccagenin and diosgenin) were isolated and their structures were confirmed. using nuclear magnetic resonance (NMR) experiments. The n-butanol extract was subjected to a separation process through column chromatography to obtain five fractions. After multiple separation processes by reversed phase high performance liquid chromatography (HPLC), the most active one produced one refined fraction that contained two saponins with the same aglycone (diosgenin) and one yuccagenin based saponin. Best results of the activity were obtained with the yuccagenin derived glycoside. Rev. Biol. Trop. 56 (4): 16451652. Epub 2008 December 12.


El género Agave, familia Agavaceae, tiene más de 300 especies, con aproximadamente 16 distribuidas en toda Cuba. Una de ellas, el Agave brittoniana Trel. (ssp. brachypus), es una subespecie endémica y sus hojas son tradicionalmente utilizadas en el tratamiento de enfermedades parasitarias. Se realizaron estudios "in vitro" de la actividad de productos de esta planta frente a Trichomona vaginalis. Las hojas secas y pulverizadas fueron extraídas tres veces con una mezcla de etanol-agua (7: 3) mediante maceración a temperatura ambiente. El disolvente fue evaporado a presión reducida y el extracto fue suspendido en agua destilada, desengrasado con n-hexano, y extraído con n-butanol saturado con agua. Luego de una extracción con acetato de etilo, los productos de la hidrólisis fueron comparados con patrones de sapogeninas mediante la cromatografía de capa fina (CCD). Aislamos las sapogeninas mayoritarias (yuccagenina y diosgenina) y confirmamos sus estructuras utilizando técnicas de resonancia magnética nuclear. Por otra parte, el extracto n-butanólico fue sometido a un proceso de separación biodirigido mediante cromatografía de columna, obteniéndose cinco fracciones. Después de múltiples separaciones, la más activa rindió una fracción purificada con dos sapogeninas con el mismo aglicón (diosgenina) y un glicósido de yucagenina. Los mejores resultados de esta actividad fueron obtenidos con el glicósido derivado de la yucagenina.


Asunto(s)
Animales , Agave/química , Antiprotozoarios/farmacología , Extractos Vegetales/farmacología , Saponinas/farmacología , Trichomonas vaginalis/efectos de los fármacos , Antiprotozoarios/química , Antiprotozoarios/aislamiento & purificación , Pruebas de Sensibilidad Parasitaria , Saponinas/química , Saponinas/aislamiento & purificación
6.
Rev Biol Trop ; 56(4): 1645-52, 2008 Dec.
Artículo en Español | MEDLINE | ID: mdl-19419073

RESUMEN

The genus Agave (Agavaceae), includes more than 300 species; around 16 of them show an homogeneous distribution throughout Cuba. Agave brittoniana (ssp. brachypus), is an endemic subspecies that grows in the central region of the country and its leaves are traditionally used in the treatment of parasitic diseases. The parasite Trichomonas vaginalis causes the disease known as trichomoniasis, that infects the genital tract. To test in vitro the plant against Trichomona vaginalis, the dried and powdered leaves were extracted three times with ethanol-water (7:3) by maceration at room temperature. The solvent was removed under reduced pressure and the extract was suspended in distilled water, defatted with n-hexane, and extracted with water-saturated n-butanol. After solvent removal, a portion of the n-butanol extract was hydrolyzed. After extraction with ethyl acetate the hydrolysis products were compared with authentic sapogenins samples using thin layer chromatography (TLC). Most of the sapogenins (yuccagenin and diosgenin) were isolated and their structures were confirmed. using nuclear magnetic resonance (NMR) experiments. The n-butanol extract was subjected to a separation process through column chromatography to obtain five fractions. After multiple separation processes by reversed phase high performance liquid chromatography (HPLC), the most active one produced one refined fraction that contained two saponins with the same aglycone (diosgenin) and one yuccagenin based saponin. Best results of the activity were obtained with the yuccagenin derived glycoside.


Asunto(s)
Agave/química , Antiprotozoarios/farmacología , Extractos Vegetales/farmacología , Saponinas/farmacología , Trichomonas vaginalis/efectos de los fármacos , Animales , Antiprotozoarios/química , Antiprotozoarios/aislamiento & purificación , Pruebas de Sensibilidad Parasitaria , Saponinas/química , Saponinas/aislamiento & purificación
7.
Mem Inst Oswaldo Cruz ; 97(6): 893-6, 2002 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12386717

RESUMEN

Eighteen clinical isolates of Trichomonas vaginalis were obtained from women who attended health centers of the Government of Madrid. A total of 1,848 vaginal specimens recovered during the gynaecological examination were seeded in culture tubes containing liquid Diamond medium. Pathogenicity to mice was determined after intraperitoneal inoculation of mice by quantification of mortality and gross damage to abdominal organs. As could be expected, a broad variability was obtained, being some of the isolates more virulent than the reference strain. Regarding to metronidazole susceptibility, none resistant isolate was found but different degrees of susceptibility were determined.


Asunto(s)
Tricomoniasis/parasitología , Trichomonas vaginalis/patogenicidad , Animales , Antitricomonas/farmacología , Femenino , Humanos , Metronidazol/farmacología , Ratones , Pruebas de Sensibilidad Parasitaria , Tricomoniasis/tratamiento farmacológico , Trichomonas vaginalis/efectos de los fármacos , Virulencia
8.
Mem. Inst. Oswaldo Cruz ; 97(6): 893-896, Sept. 2002. tab
Artículo en Inglés | LILACS | ID: lil-320154

RESUMEN

Eighteen clinical isolates of Trichomonas vaginalis were obtained from women who attended health centers of the Goverment of Madrid. A total of 1,848 vaginal specimens recovered during the gynaecological examination were seeded in culture tubes containing liquid Diamond medium. Pathogenicity to mice was determined after intraperitoneal inoculation of mice by quantification of mortality and gross damage to abdominal organs. As could be expected, a broad variability was obtained, being some of the isolates more virulent than the reference strain. Regarding to metronidazole susceptibility, none resistant isolate was found but different degrees of susceptibility were determined


Asunto(s)
Humanos , Animales , Femenino , Ratones , Tricomoniasis , Trichomonas vaginalis , Antitricomonas , Metronidazol , Pruebas de Sensibilidad Parasitaria , Tricomoniasis , Trichomonas vaginalis , Virulencia
9.
Mem. Inst. Oswaldo Cruz ; 96(2): 251-6, Feb. 2001. ilus, tab
Artículo en Inglés | LILACS | ID: lil-281576

RESUMEN

Once known some biological characteristics of six Trypanosoma cruzi strains, randomly amplified polymorphic DNA (RAPD) analysis was made. Cluster analysis by UPGMA (unweighted pair group method analysis) was then applied both to biological parameters and RAPD profiles. Inspection of the UPGMA phenograms indicates identical clusters, so supporting that usefulness of biological parameters to characterization of T. cruzi strains still remains


Asunto(s)
Animales , ADN Protozoario/análisis , Técnica del ADN Polimorfo Amplificado Aleatorio/métodos , Trypanosoma cruzi/genética , Trypanosoma cruzi/fisiología , Conducta Animal/fisiología , Heterogeneidad Genética
10.
Mem. Inst. Oswaldo Cruz ; 96(1): 53-59, Jan. 2001. ilus, tab
Artículo en Inglés | LILACS | ID: lil-281630

RESUMEN

Biological parameters of five Trypanosoma cruzi strains from different sources were determined in order to know the laboratory behaviour of natural populations. The parameters evaluated were growth kinetics of epimastigotes, differentiation into metacyclic forms, infectivity in mammalian cells grown in vitro and parasite susceptibility to nifurtimox, benznidazole and gentian violet. Differences in transformation to metacyclic, in the percentage of infected cells as well as in the number of amastigotes per cell were observed among the strains. Regarding to pharmacological assays, Y strain was the most sensitive to the three assayed compounds. These data demonstrate the heterogeneity of natural populations of T. cruzi, the only responsible of infection in humans


Asunto(s)
Animales , Ratones , Genética de Población , Trypanosoma cruzi/fisiología , Enfermedad de Chagas/parasitología , Variación Genética , Violeta de Genciana/farmacología , Estadios del Ciclo de Vida , Macrófagos/parasitología , Nifurtimox/farmacología , Nitroimidazoles/farmacología , Pruebas de Sensibilidad Parasitaria , Trypanosoma cruzi/efectos de los fármacos , Trypanosoma cruzi/genética , Trypanosoma cruzi/crecimiento & desarrollo , Células Vero/parasitología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA